There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Black Diamond
Tag: Arlinda Lee
Canaccord Genuity Believes Cara Therapeutics (NASDAQ: CARA) Still Has Room to Grow
In a report released today, Arlinda Lee from Canaccord Genuity maintained a Buy rating on Cara Therapeutics (CARA – Research
Canaccord Genuity Thinks Olema Pharmaceuticals’ Stock is Going to Recover
In a report released today, Arlinda Lee from Canaccord Genuity initiated coverage with a Buy rating on Olema Pharmaceuticals (OLMA
Canaccord Genuity Maintains a Buy Rating on Harpoon Therapeutics (HARP)
In a report released yesterday, Arlinda Lee from Canaccord Genuity maintained a Buy rating on Harpoon Therapeutics (HARP – Research
Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (NASDAQ: BPMC) and Irhythm Technologies (NASDAQ: IRTC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Blueprint Medicines
Cara Therapeutics (CARA) Received its Third Buy in a Row
After H.C. Wainwright and Needham gave Cara Therapeutics (NASDAQ: CARA) a Buy rating last month, the company received another Buy,
Analysts Offer Insights on Healthcare Companies: X4 Pharmaceuticals (NASDAQ: XFOR), Regeneron (NASDAQ: REGN) and Zimmer Biomet Holdings (NYSE: ZBH)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on X4 Pharmaceuticals